Faecal Calprotectin (FCAL) is a protein that is released into the intestines in excess when there is any inflammation. Many people with irritable bowel syndrome (IBS) have unnecessary invasive hospital investigations before their condition is diagnosed. Use of FCAL testing may lead to a reduction in the number of investigations being requested for people with a high likelihood of an IBS diagnosis. This will:
• Improve the patient experience for those with IBS and reduce the number of patients undergoing invasive procedures within secondary care.
• Reduce outpatient referrals into secondary care.
• Increase the numbers accessing rapid diagnosis for IBS/IBD.
• Improve pathways for the management of IBS.
• Provide a structured programme to aid decision making in primary care.